Characterization of ribosome stalling and no-go mRNA decay stimulated by the fragile X protein, FMRP
Journal of Biological Chemistry · 2024-08 · 300 (8) · 107540
DOI: 10.1016/j.jbc.2024.107540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-08. Verfasst von MaKenzie R Scarpitti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Pharmacology, Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Fragile X Messenger Ribonucleoprotein 1, RNA Stability, Ribosomes, RNA, Messenger. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Loss of functional fragile X mental retardation protein (FMRP) causes fragile X syndrome and is the leading monogenic cause of autism spectrum disorders and intellectual disability. FMRP is most notably a translational repressor and is thought to inhibit translation elongation by stalling ribosomes as FMRP-bound polyribosomes from brain tissue are resistant to puromycin and nuclease treatment. Here, we present data showing that the C-terminal noncanonical RNA-binding domain of FMRP is essential and sufficient to induce puromycin-resistant mRNA•ribosome complexes. Given that stalled ribosomes can stimulate ribosome collisions and no-go mRNA decay (NGD), we tested the ability of FMRP to drive NGD of its target transcripts in neuroblastoma cells. Indeed, FMRP and ribosomal proteins, but not poly(A)-binding protein, were enriched in isolated nuclease-resistant disomes compared to controls. Using siRNA knockdown and RNA-seq, we identified 16 putative FMRP-mediated NGD substrates, many of which encode proteins involved in neuronal development and function. Increased mRNA stability of four putative substrates was also observed when either FMRP was depleted or NGD was prevented via RNAi. Taken together, these data support that FMRP stalls ribosomes but only stimulates NGD of a small select set of transcripts, revealing a minor role of FMRP that would be misregulated in fragile X syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry and Pharmacology, Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
- Department of Biological Chemistry and Pharmacology, Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA. Electronic address: michael.kearse@osumc.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Scarpitti, M. R., Pastore, B., Tang, W., & Kearse, M. G. (2024). Characterization of ribosome stalling and no-go mRNA decay stimulated by the fragile X protein, FMRP. Journal of Biological Chemistry, 300(8), 107540. https://doi.org/10.1016/j.jbc.2024.107540
Vancouver
Scarpitti MR, Pastore B, Tang W, Kearse MG. Characterization of ribosome stalling and no-go mRNA decay stimulated by the fragile X protein, FMRP. Journal of Biological Chemistry. 2024;300(8):107540. doi:10.1016/j.jbc.2024.107540
BibTeX
@article{Scarpitti2024,
author = {Scarpitti, MaKenzie R and Pastore, Benjamin and Tang, Wen and Kearse, Michael G},
title = {Characterization of ribosome stalling and no-go mRNA decay stimulated by the fragile X protein, FMRP},
journal = {Journal of Biological Chemistry},
year = {2024},
volume = {300},
number = {8},
pages = {107540},
doi = {10.1016/j.jbc.2024.107540}
}
EUVIMED